Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

The prevalence and management of cardiorenal risk factors in patients with diabetic nephropathy

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 548–549 (2006)Cite this article

Access through your institution
Buy or subscribe

boxed-textSasso FC et al. (2006) Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy. Diabetes Care 29: 498–503

Background

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Adler AI et al. (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63: 225–232

    Article  Google Scholar 

  2. Lewis EJ et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851–860

    Article  CAS  Google Scholar 

  3. Brenner BM et al. (2001) RENAAL Study Investigators: effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861–869

    Article  CAS  Google Scholar 

  4. Gaede P et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383–393

    Article  Google Scholar 

  5. Stevens LA et al. (2006) Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med 354: 2473–2483

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Clinical Medicine at the James Cook University Hospital, Middlesbrough, UK

    Rudy Bilous

Authors
  1. Rudy Bilous
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Rudy Bilous.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bilous, R. The prevalence and management of cardiorenal risk factors in patients with diabetic nephropathy. Nat Rev Endocrinol 2, 548–549 (2006). https://doi.org/10.1038/ncpendmet0296

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpendmet0296

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing